首页|行气消瘿颗粒治疗气郁痰阻型甲状腺结节疗效观察

行气消瘿颗粒治疗气郁痰阻型甲状腺结节疗效观察

扫码查看
目的 观察行气消瘿颗粒治疗气郁痰阻型甲状腺结节的临床疗效.方法 选取2022 年4-12 月在陕西省中医医院诊治的 77 例气郁痰阻型甲状腺结节患者为研究对象,将患者随机分为2 组,治疗组39 例给予行气消瘿颗粒口服,对照组38 例给予夏枯草口服液口服,疗程均为3 个月.观察2 组患者中医证候评分、甲状腺结节最大直径及甲状腺功能(包括抗体)指标变化,比较2 组中医证候疗效及结节治疗效果,记录2 组不良反应发生情况.结果 2 组患者治疗后中医证候评分均明显降低,甲状腺结节最大直径均明显缩小,且治疗组较对照组改善明显,差异均有统计学意义(P均<0.05).2 组治疗前后游离三碘甲状原氨酸(FT3)、游离甲状腺素(FT4)、血清促甲状腺素(TSH)水平比较差异均无统计学意义(P均>0.05).治疗后2 组甲状腺抗体异常的甲状腺结节患者抗甲状腺过氧化物酶抗体(TPOAb)、抗甲状腺球蛋白抗体(TGAb)水平均明显降低,且治疗后治疗组TPOAb水平明显低于对照组,差异均有统计学意义(P均<0.05).治疗后对照组中医证候总有效率为 55.3%(21/38)、结节治疗总有效率为 47.4%(18/38),治疗组分别为76.9%(30/39)和74.4%(29/39),治疗组均明显高于对照组(P均<0.05).2 组均无不良反应事件发生.结论 行气消瘿颗粒治疗气郁痰阻型甲状腺结节的临床疗效佳,可降低TPOAb、TGAb水平,且安全性良好.
Therapeutic efficacy of granules for moving Qi and dispersing goiter on thyroid nodules of syndrome of Qi stagnation and phlegm obstruction
Objective It is to observe the clinical efficacy of granules for moving Qi and dispersing goiter in the treat-ment of thyroid nodules of syndrome of Qi stagnation and phlegm obstruction.Methods Seventy-seven patients with thyroid nodules of syndrome of Qi stagnation and phlegm obstruction diagnosed and treated in Shaanxi Provincial Hospital of Tradi-tional Chinese Medicine from April to December 2022 were selected as the study subjects,and were randomly divided into 2 groups:39 patients in the treatment group were given granules for moving Qi and dispersing goiter orally,and 38 patients in the control group were given Prunella oral liquid orally,both groups were treated for 3 months.The changes of scores of Chinese medicine syndromes,maximum diameter of thyroid nodules and indexes of thyroid function(including antibody)of patients in the two groups were observed,the efficacy of Chinese medicine syndrome and nodule treatment in the two groups were compared,and the occurrence of adverse reactions in the two groups was recorded.Results The scores of Chinese medicine syndromes and the maximum diameter of thyroid nodules of patients in the two groups were significantly reduced after treatment,and the improvements were more significantly in the treatment group than those in the control group,the differences were all statistically significant(all P<0.05).The differences in the levels of free triiodothyronine(FT3),free thyroxine(FT4),and thyrotropin(TSH)before and after the treatment were not statistically significant in the two groups(all P>0.05).The levels of antithyroid peroxidase antibody(TPOAb)and antithyroglobulin antibody(TGAb)were significantly lower after treatment than those before treatment in the patients of two groups with abnormal thyroid anti-bodies,and the level of TPOAb in the treatment group was significantly lower than that in the control group after treatment,the differences were all statistically significant(all P<0.05).The total effective rate of Chinese medicine syndrome was 55.3%(21/38),and the total effective rate of nodule treatment was 47.4%(18/38)in the control group,and those in the treatment group were76.9%(30/39)and74.4%(29/39),respectively,the rats of the treatment group were signifi-cantly higher than those of the control group(both P<0.05).There were no adverse reactions in the two groups.Conclu-sion Granules for moving Qi and dispersing goiter is effective in the treatment of thyroid nodules of syndrome of Qi stagna-tion and phlegm obstruction,and it can reduce the levels of TPOAb and TGAb with good safet.

thyroid nodulesgranules for moving Qi and dispersing goitersyndrome of Qi stagnation and phlegm ob-struction

周新苗、柯婷、李婷、杨甜甜、李岳、杨行、冯甜甜、王丽坤、肖洋、米烈汉

展开 >

陕西中医药大学,陕西 咸阳 712064

陕西省中医医院,陕西 西安 710003

甲状腺结节 行气消瘿颗粒 气郁痰阻

国家中医药局全国中医学术流派传承工作室建设项目(第二轮)全国名中医传承工作室建设项目米烈汉项目

国中医药人教函[2019]62号国中医药办人教函[2022]245号

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(7)
  • 24